Persistence, persistence, persistence: Lessons in device innovation from three prolific inventors
Timothy Clark, director of Interventional Radiology at Penn Presbyterian Medical Center, Philadelphia, USA and co-founder and chief executive officer of Forge Medical, which has...
From SYMPLICITY HTN-1 to SPYRAL HTN-OFF MED: The story of renal denervation
It is now almost a decade since the first patient underwent catheter-based renal denervation as a participant in a safety and proof-of concept study...
Y-90 experience in HCC crosses 1,000-patient milestone
“We are most enthusiastic about the use of radioembolization to treat patients with early stage Barcelona Clinic Liver Cancer (BCLC) A disease. The long time...
Same day Y-90 treatment could become paradigm of the future
While further refining where radioembolization should optimally lie in current treatment paradigms for the most common liver-confined or liver-dominant cancers is important, a honing...
(Visited 871 times, 1 visits today)
